Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Key Driver in Gastric Cancer Progression Uncovered
August 2025
A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
Read more
19 May 2023
Does Elevated BMI in Adulthood Heighten Gastrointestinal Cancer Risk?
Obesity is associated with an increased risk for numerous different cancer types, including gastrointestinal cancers.
19 May 2023
Connection Found Between Cancer Risk and Asthma
Studies reveal that patients with asthma have an elevated risk for several cancer types, (blood, melanoma, ovarian, kidney, and lung cancers)
22 Apr 2022
Solving the Mystery of PD-1 Inhibitors
Solved the mystery of how programmed cell death protein 1 (PD-1) inhibitors work on the immune system’s natural killer (NK) cells…
22 Apr 2022
Can Vitamin E Enhance Immunotherapy Responses?
VITAMIN E could boost immunotherapy responses, according to researchers at The University of Texas MD Anderson Cancer Center…
29 Mar 2022
Novel Drug Approved for Treatment of Rare Lung Cancer
A new oral, targeted therapeutic has been approved for the treatment of a rare non-small cell lung cancer, offering improved outcomes…
28 Jan 2022
Are AI systems Ready to be Introduced into Prostate Cancer Care?
AI systems can identify and grade prostate cancer tissue samples as accurately as pathologists, which could lead to their use as a complementary tool…
28 Jan 2022
Experts Concerned by the Rise in Young-Onset Cancers
Evidence revealed by researchers at Flinders University and UCLA has demonstrated a rise in gastrointestinal cancers in those under 50…
8 Nov 2021
Amivantamab Successfully Prolongs Survival in Rare Lung Cancer Mutation
Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer
Loading posts...
« Previous
1
…
26
27
28
29
30
…
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View